Citius Pharmaceuticals (CTXR) Earnings Date & Reports

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

CTXR is expected to report earnings to fall 103.27% to 3 cents per share on August 17

Citius Pharmaceuticals CTXR Stock Earnings Reports

Q2'26

Est.

$0.03

Q1'26

Missed

by $0.75

Q3'25

Missed

by $0.51

Q2'25

Missed

by $0.85

Q1'25

Missed

by $1.31

The last earnings report on May 15 showed earnings per share of -94 cents, missing the estimate of -20 cents. With 65.19K shares outstanding, the current market capitalization sits at 15.96M.

View a ticker or compare two or three

Compare

CTXR

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for CTXR